Cargando…

Clinical prognostic significance of serum high mobility group box-1 protein in patients with community-acquired pneumonia

OBJECTIVE: To investigate the relationship between serum high mobility group box-1 protein (HMGB-1) levels and prognosis in patients with community-acquired pneumonia (CAP). METHODS: This prospective study included 35 patients who attended our hospital from January 2016 to December 2016. Pneumonia s...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Huasong, Zeng, Nengyong, Chen, Quanfang, Wu, Yanbin, Cai, Shuanqi, Li, Gengshen, Li, Fei, Kong, Jinliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421397/
https://www.ncbi.nlm.nih.gov/pubmed/30732500
http://dx.doi.org/10.1177/0300060518819381
_version_ 1783404232494284800
author Lu, Huasong
Zeng, Nengyong
Chen, Quanfang
Wu, Yanbin
Cai, Shuanqi
Li, Gengshen
Li, Fei
Kong, Jinliang
author_facet Lu, Huasong
Zeng, Nengyong
Chen, Quanfang
Wu, Yanbin
Cai, Shuanqi
Li, Gengshen
Li, Fei
Kong, Jinliang
author_sort Lu, Huasong
collection PubMed
description OBJECTIVE: To investigate the relationship between serum high mobility group box-1 protein (HMGB-1) levels and prognosis in patients with community-acquired pneumonia (CAP). METHODS: This prospective study included 35 patients who attended our hospital from January 2016 to December 2016. Pneumonia severity was defined by pneumonia severity index (PSI). Serum levels of C-reactive protein (CRP), cortisol, and HMGB-1 were analyzed in relation to disease severity and clinical outcome. RESULTS: High HMGB-1 levels were associated with high cortisol levels. High HMGB-1 and high cortisol were both significantly associated with high white blood cell count and high serum CRP, compared with low HMGB-1 and low cortisol, respectively. PSI score and 30-day mortality were also significantly higher in patients with high HMGB-1 or high cortisol levels compared with patients with low HMGB-1 or cortisol levels, respectively. CRP, cortisol, and HMGB-1 levels were all significantly higher in patients who died compared with survivors. CONCLUSION: HMGB-1 was associated with clinical outcomes and was an independent risk factor for 30-day mortality in patients with CAP. Serum HMGB-1 levels were also positively correlated with serum levels of cortisol. These results demonstrate a role for HMGB-1 in CAP, and suggest possible new therapeutic targets for patients with CAP.
format Online
Article
Text
id pubmed-6421397
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-64213972019-03-22 Clinical prognostic significance of serum high mobility group box-1 protein in patients with community-acquired pneumonia Lu, Huasong Zeng, Nengyong Chen, Quanfang Wu, Yanbin Cai, Shuanqi Li, Gengshen Li, Fei Kong, Jinliang J Int Med Res Clinical Research Reports OBJECTIVE: To investigate the relationship between serum high mobility group box-1 protein (HMGB-1) levels and prognosis in patients with community-acquired pneumonia (CAP). METHODS: This prospective study included 35 patients who attended our hospital from January 2016 to December 2016. Pneumonia severity was defined by pneumonia severity index (PSI). Serum levels of C-reactive protein (CRP), cortisol, and HMGB-1 were analyzed in relation to disease severity and clinical outcome. RESULTS: High HMGB-1 levels were associated with high cortisol levels. High HMGB-1 and high cortisol were both significantly associated with high white blood cell count and high serum CRP, compared with low HMGB-1 and low cortisol, respectively. PSI score and 30-day mortality were also significantly higher in patients with high HMGB-1 or high cortisol levels compared with patients with low HMGB-1 or cortisol levels, respectively. CRP, cortisol, and HMGB-1 levels were all significantly higher in patients who died compared with survivors. CONCLUSION: HMGB-1 was associated with clinical outcomes and was an independent risk factor for 30-day mortality in patients with CAP. Serum HMGB-1 levels were also positively correlated with serum levels of cortisol. These results demonstrate a role for HMGB-1 in CAP, and suggest possible new therapeutic targets for patients with CAP. SAGE Publications 2019-02-07 2019-03 /pmc/articles/PMC6421397/ /pubmed/30732500 http://dx.doi.org/10.1177/0300060518819381 Text en © The Author(s) 2019 http://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Clinical Research Reports
Lu, Huasong
Zeng, Nengyong
Chen, Quanfang
Wu, Yanbin
Cai, Shuanqi
Li, Gengshen
Li, Fei
Kong, Jinliang
Clinical prognostic significance of serum high mobility group box-1 protein in patients with community-acquired pneumonia
title Clinical prognostic significance of serum high mobility group box-1 protein in patients with community-acquired pneumonia
title_full Clinical prognostic significance of serum high mobility group box-1 protein in patients with community-acquired pneumonia
title_fullStr Clinical prognostic significance of serum high mobility group box-1 protein in patients with community-acquired pneumonia
title_full_unstemmed Clinical prognostic significance of serum high mobility group box-1 protein in patients with community-acquired pneumonia
title_short Clinical prognostic significance of serum high mobility group box-1 protein in patients with community-acquired pneumonia
title_sort clinical prognostic significance of serum high mobility group box-1 protein in patients with community-acquired pneumonia
topic Clinical Research Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421397/
https://www.ncbi.nlm.nih.gov/pubmed/30732500
http://dx.doi.org/10.1177/0300060518819381
work_keys_str_mv AT luhuasong clinicalprognosticsignificanceofserumhighmobilitygroupbox1proteininpatientswithcommunityacquiredpneumonia
AT zengnengyong clinicalprognosticsignificanceofserumhighmobilitygroupbox1proteininpatientswithcommunityacquiredpneumonia
AT chenquanfang clinicalprognosticsignificanceofserumhighmobilitygroupbox1proteininpatientswithcommunityacquiredpneumonia
AT wuyanbin clinicalprognosticsignificanceofserumhighmobilitygroupbox1proteininpatientswithcommunityacquiredpneumonia
AT caishuanqi clinicalprognosticsignificanceofserumhighmobilitygroupbox1proteininpatientswithcommunityacquiredpneumonia
AT ligengshen clinicalprognosticsignificanceofserumhighmobilitygroupbox1proteininpatientswithcommunityacquiredpneumonia
AT lifei clinicalprognosticsignificanceofserumhighmobilitygroupbox1proteininpatientswithcommunityacquiredpneumonia
AT kongjinliang clinicalprognosticsignificanceofserumhighmobilitygroupbox1proteininpatientswithcommunityacquiredpneumonia